These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7421180)

  • 1. Is potassium a necessary component of cardioplegic solutions?
    Grover FL; Fewel JG; Ghidoni JJ; Arom KV; Trinkle JK
    J Surg Res; 1980 Jul; 29(1):62-70. PubMed ID: 7421180
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of coenzyme Q10 added to a potassium cardioplegic solution for myocardial protection during ischemic cardiac arrest.
    Mori F; Mohri H
    Ann Thorac Surg; 1985 Jan; 39(1):30-6. PubMed ID: 3966834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury.
    Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical importance of ensuring cardioplegic delivery with coronary stenoses.
    Becker H; Vinten-Johansen J; Buckberg GD; Follette DM; Robertson JM
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):507-15. PubMed ID: 7206757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroperfusion of the heart with a solution of glucose, insulin, and potassium during anoxic arrest.
    Lolley DM; Hewitt RL; Drapanas T
    J Thorac Cardiovasc Surg; 1974 Mar; 67(3):364-70. PubMed ID: 4813438
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of roller pump versus pressurized bag administration of potassium cardioplegic solution.
    Grover FL; Fewel JG; Ghidoni JJ; Bennett EV; Trinkle JK
    Ann Thorac Surg; 1982 Sep; 34(3):278-86. PubMed ID: 7114946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electron microscopic observations on the protection of the ischemic myocardium in dogs by intermittent perfusion with cold cardioplegic solutions and intermittent perfusion with cold blood].
    Yao XJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Sep; 12(3):213-5, 239. PubMed ID: 6532769
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolic consequences of blood and crystalloid cardioplegia.
    Engelman RM; Rousou JH; Lemeshow S; Dobbs WA
    Circulation; 1981 Aug; 64(2 Pt 2):II67-74. PubMed ID: 6972829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold blood potassium cardioplegia. Effects of increasing concentrations of potassium.
    Jellinek M; Standeven JW; Menz LJ; Hahn JW; Barner HB
    J Thorac Cardiovasc Surg; 1981 Jul; 82(1):26-37. PubMed ID: 7242128
    [No Abstract]   [Full Text] [Related]  

  • 10. The significance of persistent myocardial perfusion during aortic cross-clamping in myocardial protection.
    Wittnich C; Chiu RC
    J Thorac Cardiovasc Surg; 1983 Apr; 85(4):612-7. PubMed ID: 6601217
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial function, blood flow, and metabolism with different forms of myocardial protection.
    Klooker P; Hilse B; Mittmann U; Saggau WW; Späth J; Storch H
    Thorac Cardiovasc Surg; 1982 Dec; 30(6):393-400. PubMed ID: 6187099
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold blood as the vehicle for potassium cardioplegia.
    Barner HB; Laks H; Codd JE; Standeven JW; Jellinek M; Kaiser GC; Menz LJ; Tyras DH; Pennington DG; Hahn JW; Willman VL
    Ann Thorac Surg; 1979 Dec; 28(6):509-21. PubMed ID: 518180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal intraoperative protection of myocardium distal to coronary stenoses.
    Silverman NA; Schmitt G; Levitsky S; Feinberg H
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):424-31. PubMed ID: 6433111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of prolonged aortic clamping with blood cardioplegia. II. Glutamate enrichment in energy-depleted hearts.
    Rosenkranz ER; Okamoto F; Buckberg GD; Vinten-Johansen J; Robertson JM; Bugyi H
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):402-10. PubMed ID: 6147442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does lower systemic temperature enhance cardioplegic myocardial protection?
    Grover FL; Fewel JG; Ghidoni JJ; Trinkle JK
    J Thorac Cardiovasc Surg; 1981 Jan; 81(1):11-20. PubMed ID: 7453211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is an ideal cardioplegic solution?
    Saw HS
    Ann Acad Med Singap; 1981 Apr; 10(2):165-74. PubMed ID: 7332277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of single-dose and multiple-dose crystalloid and blood potassium cardioplegia during prolonged hypothermic aortic occlusion.
    Takamoto S; Levine FH; LaRaia PJ; Adzick NS; Fallon JT; Austen WG; Buckley MJ
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):19-28. PubMed ID: 7350385
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardioplegic hemoglobin perfusion: a method of providing optimal myocardial protection.
    Elert O; Ottermann U
    Thorac Cardiovasc Surg; 1979 Aug; 27(4):245-7. PubMed ID: 162775
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial recovery after hypothermic arrest: a comparison of oxygenated crystalloid to blood cardioplegia. The role of calcium.
    Heitmiller RF; DeBoer LW; Geffin GA; Toal KW; Fallon JT; Drop LJ; Teplick RS; O'Keefe DD; Daggett WM
    Circulation; 1985 Sep; 72(3 Pt 2):II241-53. PubMed ID: 4028363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.